Laboratory of Physiology, Graduate School of Nutritional and Environmental Sciences, Institute for Environmental Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan.
J Mol Histol. 2011 Feb;42(1):27-38. doi: 10.1007/s10735-010-9304-4. Epub 2010 Nov 28.
Glucagon-like peptide 1 (GLP-1) is a multifunctional hormone in glucose metabolism and intestinal function released by enteroendocrine L-cells. The plasma concentration of GLP-1 is increased by indigestible carbohydrates and luminal infusion of short-chain fatty acids (SCFAs). However, the triggers and modulators of the GLP-1 release remain unclear. We hypothesized that SCFAs produced by bacterial fermentation are involved in enteroendocrine cell proliferation and hormone release through free fatty acid receptor 2 (FFA2, also known as FFAR2 or GPR43) in the large intestine. Fructo-oligosaccharide (Fructo-OS), fermentable indigestible carbohydrate, was used as a source of SCFAs. Rats were fed an indigestible-carbohydrate-free diet (control) or a 5% Fructo-OS-containing diet for 28 days. FFA2-, GLP-1-, and 5-hydroxytryptamine (5-HT)-positive enteroendocrine cells were quantified immunohistochemically in the colon, cecum, and terminal ileum. The same analysis was performed in surgical specimens from human lower intestine. The coexpression of FFA2 with GLP-1 was investigated both in rats and humans. Fructo-OS supplementation in rats increased the densities of FFA2-positive enteroendocrine cells in rat proximal colon, by over two-fold, relative to control, in parallel with GLP-1-containing L-cells. The segmental distributions of these cells in human were similar to rats fed the control diet. The FFA2-positive enteroendocrine cells were GLP-1-containing L-cells, but not 5-HT-containing EC cells, in both human and rat colon and terminal ileum. Fermentable indigestible carbohydrate increases the number of FFA2-positive L-cells in the proximal colon. FFA2 activation by SCFAs might be an important trigger for produce and release GLP-1 by enteroendocrine L-cells in the lower intestine.
胰高血糖素样肽 1(GLP-1)是一种在葡萄糖代谢和肠道功能中发挥作用的多功能激素,由肠内分泌 L 细胞分泌。不可消化的碳水化合物和短链脂肪酸(SCFAs)的肠腔输注会增加 GLP-1 的血浆浓度。然而,GLP-1 释放的触发因素和调节剂仍不清楚。我们假设,细菌发酵产生的 SCFAs 通过大肠中的游离脂肪酸受体 2(FFA2,也称为 FFAR2 或 GPR43)参与肠内分泌细胞的增殖和激素释放。低聚果糖(Fructo-OS)是一种可发酵的不可消化的碳水化合物,用作 SCFAs 的来源。大鼠喂食不可消化碳水化合物的饮食(对照)或 5%低聚果糖饮食 28 天。通过免疫组织化学在结肠、盲肠和回肠中定量 FFAR2、GLP-1 和 5-羟色胺(5-HT)阳性肠内分泌细胞。对来自人类下消化道的手术标本进行了相同的分析。在大鼠和人类中均研究了 FFAR2 与 GLP-1 的共表达。与对照相比,大鼠补充低聚果糖使大鼠近端结肠中 FFAR2 阳性肠内分泌细胞的密度增加了两倍以上,与含 GLP-1 的 L 细胞平行增加。这些细胞在人类中的节段分布与喂食对照饮食的大鼠相似。在人和大鼠的结肠和回肠中,FFA2 阳性肠内分泌细胞是含 GLP-1 的 L 细胞,而不是含 5-HT 的 EC 细胞。可发酵的不可消化的碳水化合物增加了近端结肠中 FFAR2 阳性 L 细胞的数量。SCFAs 对 FFA2 的激活可能是肠内分泌 L 细胞在下消化道产生和释放 GLP-1 的重要触发因素。